Delve Health is looking to expand its Business Development team with two new team members.

Delve Health is a clinical trial execution partner focused on one critical gap: what happens between visits. While most platforms capture data, Delve ensures that data is actually collected—consistently, reliably, and at scale. Through a unified model that combines eCOA/ePRO, wearable integration, and Concierge-as-a-Service™, we actively manage patient compliance, engagement, and data integrity across the full study lifecycle. Our Clinical StudyPal™ platform enables sponsors, CROs, and research sites to deploy digital endpoints, remote assessments, and hybrid trial models without adding operational burden. We support a wide range of therapeutic areas including cardiology, oncology, CNS, dermatology, metabolic disease, and rare conditions—where long-term follow-up and adherence are critical to success. What makes Delve different is execution ownership. At the core of this is our Concierge-as-a-Service™ model—a dedicated human layer assigned to every patient. This is not traditional support. Our protocol-trained, multilingual concierge team actively engages patients, reinforces study requirements, resolves issues in real time, and closes the loop on missed activities. Where technology can remind, humans ensure follow-through. We don’t rely on passive dashboards. Our platform and concierge team work together to detect early signs of drift—missed diaries, declining device use, disengagement—and intervene before they impact endpoints. This results in consistently high performance across studies, including >92% ePRO completion and >95% device compliance. Delve consolidates what is typically fragmented across multiple vendors—eCOA, wearables, engagement, and support—into a single, coordinated solution. This reduces complexity, improves visibility, and strengthens dataset integrity. Whether supporting post-market studies, decentralized trials, or real-world evidence programs, Delve ensures that execution matches protocol intent.